Program Description & Educational Objectives
In this activity, experts in gastroesophageal reflux disease (GERD) discuss updates in the diagnosis and management of GERD from the American College of Gastroenterology 2011 Annual Scientific Meeting.
Upon completion of this activity, participants should be better able to:
- Evaluate recent clinical and health economics data related to the management of gastrointestinal reflux disease (GERD)
- Identify current issues and controversies associated with the diagnosis and treatment of GERD
- Implement an evidence-based and resource-efficient strategy for the diagnosis and treatment of GERD
- Improve clinician-patient communication surrounding the physical and psychological symptom burdens of GERD, identifying patients’ dissatisfaction with current treatment options for GERD
Target Audience
This activity has been designed to meet the educational needs of primary care physicians and other clinicians involved in the management of patients with gastroesophageal reflux disease.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Media: Internet
Release and Expiration Dates: December 21, 2011 - December 20, 2012
Time to Complete: 30 minutes
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, the University of New Mexico Health Sciences Center, School of Medicine, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by UNM CME and conflicts of interest were resolved prior to the activity.
Course Director and Interviewee
Philip O. Katz, MD, FACG
Chairman, Division of Gastroenterology
Einstein Medical Center
Clinical Professor of Medicine
Thomas Jefferson University
Philadelphia, Pennsylvania
Philip O. Katz, MD, FACG,
has a financial interest/relationship or affiliation in the form of:
Consultant for AstraZeneca; Eisai Inc.; Intec Pharma ltd.; Ironwood Pharmaceuticals, Inc.; Novartis Consumer Health; Sunovion Pharmaceuticals Inc.; and Takeda Pharmaceuticals North America, Inc.
Interviewee
David A. Katzka, MD
Professor of Medicine
Mayo Clinic College of Medicine
Director of Esophageal Interest Group
Mayo Clinic
Rochester, Minnesota
David A. Katzka, MD,
currently has no financial interests/relationships or affiliations in relation to this activity.
CME Reviewer
Sanjeev Arora, MD
Professor of Medicine
Department of Internal Medicine
Director, Project ECHO
University of New Mexico Health Sciences Center School of Medicine
Albuquerque, New Mexico
Sanjeev Arora, MD,
currently has no financial interests/relationships or affiliations in relation to this activity.
Content Director
Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education
Kathryn B. Charalambous, PhD,
currently has no financial interests/relationships or affiliations in relation to this activity.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of New Mexico Health Sciences Center, School of Medicine and PVI, PeerView Institute for Medical Education. The University of New Mexico Health Sciences Center, School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of New Mexico Health Sciences Center, School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This CME activity is jointly sponsored by the University of New Mexico Health Sciences Center, School of Medicine and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from 
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.
